Filter
308
Text search:
German
Doctors
Featured
35
82
Language
Document type
168
68
20
16
9
9
7
4
4
3
Countries / Regions
37
28
11
11
9
8
7
7
6
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
82
22
13
13
10
4
1
1
Toolboxes
56
40
22
17
15
13
12
10
10
9
8
7
6
5
3
2
2
1
1
1
1
Guidebook on ICD10
recommended
3rd edition
For practitioners in humanitarian and development contexts
National Tuberculosis and Leprosy Conrol Programme
Experience of national TB partnerships
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
There is a substantial and ever-increasing unmet need for rehabilitation worldwide, which is particularly profound in low- and middle
-income countries. The availability of accessible and affordable rehabilitation is necessary for many people with health conditions to remain as independent as possi
...
A Manual for Maternity Unit Personnel - Part of the CBM Prevention Toolkit on Birth Impairments
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic assessment instrument developed by WHO to provide a standardized method for measuring health and disability across cultures. It was developed from a comprehensive set of International Classification of Functioning
...
The Road Map outlines various strategies which will guide policy makers, development partners, training institutions and service providers in supporting Government efforts towards the attainment of MDGs related to maternal and neonatal health.
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac
...
Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers
summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It a
...
